$3.22
+
$0.22 (7.33%)
End-of-day quote: 05/16/2024
NasdaqCM:HRTX
Heron Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.28 | $174.55 | 0.00% | 3 | $371.30B |
| MRK | Merck | NYSE | Outperform | $130.88 | $130.51 | 0.00% | 11 | $331.49B |
| ROG | Roche Holding | SWX | Hold | CHF234.80 | CHF307.83 | 0.00% | 9 | CHF189.54B |
| SAN | Sanofi | ENXTPA | Outperform | 90.24€ | 102.80€ | 0.00% | 9 | 112.81€B |
| 4151 | Kyowa Kirin | TSE | Outperform | ¥2.65k | ¥3.06k | 0.00% | 0 | ¥1.41T |
| CPIX | Cumberland Pharmaceuticals | NasdaqGS | - | $2.03 | $8.50 | 0.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | NasdaqGM | Outperform | $1.15 | $4.63 | 0.00% | 0 | $17.33M |
| TRVN | Trevena | NasdaqCM | Outperform | $0.61 | $5.18 | 0.00% | 0 | $9.38M |
| BXRX | Baudax Bio | OTCPK | - | $0.01 | $24.00 | 0.00% | 0 | $1.16M |
